Pfizer Inc
Change company Symbol lookup
Select an option...
PFE Pfizer Inc
SCBH Seacoast Commerce Banc Holdings
PHX Panhandle Oil and Gas Inc
BTU Peabody Energy Corp
CLNY Colony Capital Inc
BAC Bank of America Corp
USAK USA Truck Inc
BABA Alibaba Group Holding Ltd
CTL Centurylink Inc
CSCO Cisco Systems Inc
Go

Health Care : Pharmaceuticals | Large Cap Value
Company profile

Pfizer Inc. (Pfizer) is a research-based global biopharmaceutical company. The Company is engaged in the discovery, development and manufacture of healthcare products. Its global portfolio includes medicines and vaccines. The Company manages its commercial operations through two business segments: Pfizer Innovative Health (IH) and Pfizer Essential Health (EH). IH focuses on developing and commercializing medicines and vaccines. IH therapeutic areas include internal medicine, vaccines, oncology, inflammation and immunology, rare diseases and consumer healthcare. EH includes legacy brands, branded generics, generic sterile injectable products, biosimilars and infusion systems. EH also includes a research and development (R&D) organization, as well as its contract manufacturing business. Its brands include Prevnar 13, Xeljanz, Eliquis, Lipitor, Celebrex, Pristiq and Viagra.

Closing Price
$40.34
Day's Change
-0.17 (-0.42%)
Bid
--
Ask
--
B/A Size
--
Day's High
40.66
Day's Low
40.19
Volume
(Above Average)
Volume:
21,931,425

10-day average volume:
18,733,548
21,931,425

Values displayed are in millions.

Q4 2018
12/31/18
Q1 2019
03/31/19
Q2 2019
06/30/19
Q3 2019
09/29/19
Net Income11,1883,8898,94516,628
Depreciation/Depletion6,3841,5453,0734,626
Deferred Taxes(2,205)(60)(160)2,067
Discontinued Operations(1)------
Extraordinary Item(596)(131)(285)(319)
Unusual Items3,398155178(8,009)
Other Non-Cash Items(319)(51)(78)(174)
Non-Cash Items2,482(27)(185)(8,502)
Cash Taxes Pd, Supplemental3,6552352,1362,636
Cash Interest Pd, Suppl1,3113858091,246
Accounts Receivable(644)------
Inventories(717)------
Other Assets(16)------
Accounts Payable431------
Accrued Expenses(1,095)(151)(313)(429)
Changes in Working Capital(2,022)(3,650)(7,363)(6,001)
Total Cash from Operations15,8271,6974,3108,818

Values displayed are in millions.

Q4 2018
12/31/18
Q1 2019
03/31/19
Q2 2019
06/30/19
Q3 2019
09/29/19
Purchase of Fixed Assets(2,042)(460)(939)(1,504)
Purchase/Acq of Intangibles(154)(158)(267)(364)
Capital Expenditures(2,196)(618)(1,206)(1,868)
Acquisition of Business0----(10,861)
Sale/Maturity of Investment23,8253,6456,1437,882
Investment, Net(3,917)5,9414,7178,307
Purchase of Investments(13,474)(1,486)(4,186)(4,717)
Other Investing Cash Flow28768180145
OtherInvestCashFlowItms,Tot6,7218,1686,854756
Total Cash from Investing4,5257,5505,648(1,112)

Values displayed are in millions.

Q4 2018
12/31/18
Q1 2019
03/31/19
Q2 2019
06/30/19
Q3 2019
09/29/19
Financing Cash Flow Items(589)(496)(541)(666)
Total Cash Dividends Paid(7,978)(2,045)(4,047)(6,051)
Common Stock, Net(12,198)(8,865)(8,865)(8,865)
Options Exercised1,259126248303
Iss (Retirmnt) of Stock,Net(10,939)(8,739)(8,617)(8,562)
Short Term Debt Issued3,7116093,95611,582
Short Term Debt Reduction(4,437)(1,766)(2,375)(4,088)
Short Term Debt, Net(2,343)8754,30010,098
Long Term Debt Issued4,9744,9424,9424,942
Long Term Debt Reduction(3,566)(3,004)(5,355)(5,806)
Long Term Debt, Net1,4081,938(413)(864)
Iss (Retirmnt) of Debt, Net(935)2,8133,8879,234
Total Cash From Financing(20,441)(8,467)(9,318)(6,045)

Values displayed are in millions.

Q4 2018
12/31/18
Q1 2019
03/31/19
Q2 2019
06/30/19
Q3 2019
09/29/19
Foreign Exchange Effects(116)12(28)(41)
Net Change in Cash(205)7926121,620
NetCash-BeginBal/RsvdforFutUse1,4311,2251,2251,225
NetCash-EndBal/RsrvforFutUse1,2252,0181,8372,846
Depreciation, Supplemental6,3841,5453,0734,626
Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Copyright © 2020. All rights reserved.

Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.

Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.